Halal Pharmacore Market Tracker

The most up-to-date halal pharmaceutical news content in the world.

Top News

All News

Unleashing Potential: The Rise of the Global Halal Market

Experience the exponential growth of the global halal market, projected to reach $7.7 trillion by 2025. This surge is driven by sectors such as Islamic finance, food and beverage, pharmaceuticals, and more. With consumer spending on halal products expected to hit $2.4 trillion in 2024, the halal industry presents a promising economic sector for investment. Join us in this journey as we explore the untapped potential of the halal market

Unlocking the Halal Goldmine: Invest in the Philippine’s Thriving Halal Market

Philippines aims to become a premier halal hub by 2028, tapping into the $7.7 trillion global halal industry. The strategic plan includes increasing halal-certified products and generating PHP230 billion in domestic halal sector investments. This presents a thriving market for investors, with potential for significant domestic growth and job creation.

Halal Horizons: A Global Convergence at the Makkah Halal Forum

The Makkah Halal Forum, organized by the Islamic Chamber Halal Services and Manafea, is a pioneering event aimed at revolutionizing the global Halal Market. The forum will host workshops, panels, and exhibitions to address critical issues in the Halal economy and meet the needs of Muslim consumers. This 3-day event promotes cross-sector collaborations and drives the growth of the Halal market globally.

Philippines to Launch National Halal Strategy

The plan aims to generate $4 billion in trade and investments in all halal sectors including halal food, Islamic finance, halal-friendly travel and tourism, modest fashion, halal pharmaceuticals, and cosmetics.

Malaysia: Building Local Halal Champions

Malaysia to compete globally in the growing halal industry by building a strong halal ecosystem, including infrastructure, regulation, and industry expertise, through collaboration between public and private sectors.

Abdi Ibrahim Purchased OM Pharma’s Shares

he leading Turkish pharmaceutical company Abdi Ibrahim purchased 28.5 per cent of the shares of the Swiss biotech company OM Pharma for TL 4.2 billion (USD 530 million), making it the company’s second-largest shareholder.